Selected Review Articles

  1. Kiwaki T, Kataoka H: Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine． J Pers Med,12: 695 (2022)
  2. Nishida T, Kataoka H: Glypican 3-targeted therapy in hepatocellular carcinoma． Cancers,11: 1339 (2019)
  3. 山本晃士、川口真紀子、片岡寛章：腸上皮の正常性維持に不可欠な細胞膜結合セリンプロテアーゼ制御機構． メディカルサイエンスダイジェスト,45: 622-625 (2019)
  4. 山本晃士、川口真紀子、片岡寛章：腸上皮の完全性維持における細胞膜結合セリンプロテアーゼ制御の重要性． BIO Clinica,34: 100-104 (2019)
  5. Fukushima T, Uchiyama S, Tanaka T, Kataoka H: Hepatocyte growth factor activator: a proteinase linking tissue injury with repair. Int. J Mol. Sci., 19: 3435 (2018)
  6. 片岡寛章; 新たな上皮完全性維持機構 − 細胞膜結合型セリンプロテアーゼとインヒビター． 実験医学,36: 438-444 (2018)
  7. Kataoka H, Shimomura T:CHaptor 3; HGF Activator (HGFA) and its inhibitors HAI-1 and HAI-2: Key players in tissue repair and cancer. Extracellular Targeting of Cell Signaling in Cancer: Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways., Jul 2018
  8. Kataoka H, Kawaguchi M, Fukushima T, Shimomura T: Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer. Pathol Int., 68:145-158 (2018)
  9. Kataoka H, Fukushima T: Chaptor 9; Pericellular Activation of Peptide Growth Factors by Serine Proteases. In: Current Human Cell Research and Applications. Regulation of Signal Transduction in Human Cell Research. ISBN: 978-981-10-7295-6,pp 183-197 (2017)
  10. 片岡寛章、川口真紀子、田中弘之、福島　剛; プロテアーゼによるがん間質モジュレーション． 病理と臨床,32: 10-36 (2014)
  11. Ishida Y, Takeshita M, Kataoka H: Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism. World J. Hepatol, 6 ,870-879 (2014)
  12. Kawaguchi M, Kataoka H: Mechanisms of Hepatocyte Growth Factor Activation in Cancer. Cancers, 6 (4), 1890-1904 (2014)
  13. Yorita K, Ohno A, Kataoka H: Emerging histopathological prognostic biomarkers in hepatocellular carcinomas. Personalized Medicine Universe, 3:15?21 (2014)
  14. Kataoka H: Hepatocyte Growth Factor Activator. pp3016-3020. In: Rawlings ND & Salvesen GS (Eds.) Handbook of Proteolytic Enzymes, third edition. Oxford: Academic Press. (2013)
  15. Fukushima T: Chaptor 5; Alkylating Agents and Treatment of Gliomas. pp. 145-171 . In: Yildiz Dincer eds. Alkylating Agents as Environmental Carcinogen and Chemotherapy Agents. ISBN: 978-1-62618-487-9, Nova Science Publisher, Inc. (2013)
  16. Fukushima T and kataoka H: Chaptor 19; Insulin-Like Growth Factor Binding Protein-2: A Possible Regulator of Invasive Growth in Glioblastoma. In: Miklos Garami eds. Molecular Targets of CNS Tumors, ISBN: 978-953-307-736-9, InTech (2011)
  17. Kataoka H: Hepatocyte growth factor activator (HGFA): introduction. FEBS J 277:2207, 2010
  18. Kataoka H, Kawaguchi M: Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo. FEBS J 277:2230-2237, 2010
  19. Kataoka H: SPINT1 (serine peptidase inhibitor, Kunitz type 1). Atlas Genet Cytogenet Oncol Haematol. (2009)
  20. Fukushima T, Takeshima H, and Kataoka H: Anti-Glioma Therapy with Temozolomide and Status of the DNA-Repair Gene MGMT. Anticancer Res. 29:4845-4854 (2009)
  21. Fukushima T and Kataoka H: Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. Anticancer Res., 27:3685-3692 (2007)
  22. Yamada G, Suzuki K, Haraguchi R, Miyagawa S, Satoh Y, Kamimura M, Nakagata N, Kataoka H, Kuroiwa A, and Chen Y: Molecular genetic cascades for external genitalia formation: An emerging organogenesis program. Dev. Dyn., 235:1738-1752 (2006)
  23. Itoh H, Naganuma S, Uchiyama S, Nagaike K, Tanaka H, and Kataoka H: Activation of hepatocyte growth factor/scatter factor is required in colorectal carcinoma and injured intestinal mucosa. Recent Res. Devel. Biophys. Biochem., 4:1-16 (2004)
  24. Kataoka H, Tanaka H, Nagaike K, Uchiyama S, and Itoh H: Role of cancer cell-stroma interaction in invasive growth of cancer cells. Hum. Cell, 16:1-14 (2003)
  25. Kataoka H, Miyata S, Uchinokura S, and Itoh H: Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metast. Rev. 22:223-236 (2003)
  26. Itoh H and Kataoka H: Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. J. Gastroenterol., 37:15-21 (2002)
  27. Kataoka H, Itoh, H, and Koono M: Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol. Int., 52:89-102 (2002)
  28. Kataoka H, Akiyama Y, Seguchi T, Naganuma S, and Itoh H: Immunohistochemical analysis if hepatocyte growth factor activator and its inhibitor HAI-1: Implication for regeneration of injured tissue and tumor progression. Recent Res. Devel. Histopathol. 1: 67-76 (2002)
  29. Kataoka H, Itoh H, Shimomura T, Nuki Y, Naganuma S, and Miyazawa K: Regulation of hepatocyte growth factor (HGF) activation on cell surface: Insights into an emerging class of cell surface protease inhibitors. Int. Archiv Cell Biol., 1:1036-1042 (2001)
  30. Kataoka H, Itoh H, Hamasuna R, Meng J-Y, and Koono M: Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: Roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Human Cell, 14:83-93 (2001)
  31. Uchino H, Kataoka H, Itoh H, Sekiya R, Onitsuka T, and Koono M:Roles of intestinal trefoil factor (ITF) in human colorectal cancer: ITF suppresses the growth of colorectal carcinoma cells. Hum. Cell, 12:181-188 (1999)
  32. Nabeshima K, Inoue T, Shimao Y, Kataoka H, and Koono M: Cohort migration of carcinoma cells: Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol. Histopathol. 14:1183-1197 (1999)
  33. Moriyama T, Kataoka H, Koono M, and Wakisaka S: Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors (Review). Int. J. Mol. Med., 3:531-536 (1999)
  34. Nabeshima K, Inoue T, Kataoka H, and Koono M: Cohort migration of cancer cells. Connective tissue, 29:199-212 (1997)